Literature DB >> 16143949

The immune response to mitochondrial autoantigens.

Hiromi Ishibashi1, Shinji Shimoda, M Eric Gershwin.   

Abstract

Similar to other autoimmune diseases, there are intense humoral and cellular responses to intracytoplasmic antigens in primary biliary cirrhosis (PBC). The autoantigens against antimitochondrial antibodies (AMAs) in PBC are located on the inner mitochondrial membrane and are identified as members of the 2-oxo-acid dehydrogenase complexes (2-OADCs), of which the E2 subunit of pyruvate dehydrogenase complex (PDC-E2) is the major autoantigen; AMAs are is present in approximately 90 to 95% of PBC sera. An orchestrated immune response against the intrahepatic biliary epithelial cell (BEC) through 2-OADC-specific CD4 (+) helper T cells and CD8 (+) CTL are thought to be the major players in the immunological destruction of BECs in PBC. We believe that a prior/primary event of specific intrahepatic BEC malfunction (possibly caused by environmental insults such as xenobiotics and microorganisms) is responsible for the breaking of self-tolerance to 2-OADC and leads to BEC destruction. The generation of 2-OADC-specific T cells further accelerates the damage of BEC. In addition, immunoglobulin A AMAs may participate in the destruction of BECs by damaging mitochondria.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16143949     DOI: 10.1055/s-2005-916325

Source DB:  PubMed          Journal:  Semin Liver Dis        ISSN: 0272-8087            Impact factor:   6.115


  9 in total

1.  T cell targeting and phagocytosis of apoptotic biliary epithelial cells in primary biliary cirrhosis.

Authors:  Jorge Allina; Bin Hu; Daniel M Sullivan; Maria Isabel Fiel; Swan N Thung; Steven F Bronk; Robert C Huebert; Judy van de Water; Nicholas F LaRusso; M E Gershwin; Gregory J Gores; Joseph A Odin
Journal:  J Autoimmun       Date:  2007-01-10       Impact factor: 7.094

2.  Transgenic mice aberrantly expressing pyruvate dehydrogenase complex E2 component on biliary epithelial cells do not show primary biliary cirrhosis.

Authors:  K Inamura; H Tsuji; Y Nakamoto; M Suzuki; S Kaneko
Journal:  Clin Exp Immunol       Date:  2006-07       Impact factor: 4.330

3.  Diagnostic accuracy of two tests for determination of anti-m2 in the diagnosis of primary biliary cirrhosis: Is it possible to predict the course of the disease?

Authors:  Antonio Maria Alfano; Alessandra Romito; Cristiana Marchese; Marco Battistini; Giliola Crotti; Arturo Ferrini; Cristina Mancinetti; Tilde Manetta; Giulio Mengozzi; Paola Merlach; Marco Migliardi; Maria Teresa Tambuzzo
Journal:  Immunol Res       Date:  2017-02       Impact factor: 2.829

Review 4.  Update on primary biliary cirrhosis.

Authors:  Pietro Invernizzi; Carlo Selmi; M Eric Gershwin
Journal:  Dig Liver Dis       Date:  2010-03-31       Impact factor: 4.088

Review 5.  Heterogeneity of the intrahepatic biliary epithelium.

Authors:  Shannon Glaser; Heather Francis; Sharon Demorrow; Gene Lesage; Giammarco Fava; Marco Marzioni; Julie Venter; Gianfranco Alpini
Journal:  World J Gastroenterol       Date:  2006-06-14       Impact factor: 5.742

Review 6.  Primary biliary cirrhosis: what we know and what we want to know about human PBC and spontaneous PBC mouse models.

Authors:  Yoshiyuki Ueno; Yuki Moritoki; Tooru Shimosegawa; M Eric Gershwin
Journal:  J Gastroenterol       Date:  2007-03-30       Impact factor: 7.527

7.  Antimitochondrial autoantibodies in pemphigus vulgaris: a missing link in disease pathophysiology.

Authors:  Steve Marchenko; Alexander I Chernyavsky; Juan Arredondo; Vivian Gindi; Sergei A Grando
Journal:  J Biol Chem       Date:  2009-12-10       Impact factor: 5.157

Review 8.  The chemical pathway to primary biliary cirrhosis.

Authors:  Carlo Selmi; Claudio A Cocchi; Massimo Zuin; M Eric Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2009-02       Impact factor: 8.667

9.  Pathological features of new animal models for primary biliary cirrhosis.

Authors:  Koichi Tsuneyama; Yuki Moritoki; Kentaro Kikuchi; Yasuni Nakanuma
Journal:  Int J Hepatol       Date:  2011-07-06
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.